Trigger finger can turn simple things such as gripping a coffee mug, opening a jar, typing, or using tools into a frustrating cycle of pain, clicking, catching, and sometimes complete locking of a finger.
For many patients, the biggest question is not simply “How do I treat trigger finger?” It is “Should I try a cortisone injection, or is it time to consider a trigger finger release?”
Both can be reasonable treatments. They solve the problem differently, and the best choice depends on how severe the triggering is, how long it has been present, whether an injection has already failed, your medical history, and what you need your hand to do.
What is trigger finger?
Trigger finger, also called stenosing tenosynovitis, happens when a flexor tendon no longer glides smoothly through the pulley system that holds the tendon close to the finger. The A1 pulley near the base of the finger is usually the key site of narrowing.
Patients commonly notice:
- tenderness or a small painful area in the palm at the base of the affected finger;
- clicking or popping with bending and straightening;
- stiffness that may be worse in the morning;
- a finger that catches and then suddenly releases;
- needing the other hand to straighten the finger; or
- in more advanced cases, a finger that becomes locked.
Diabetes and some other medical conditions are associated with trigger finger, but many otherwise healthy people develop it as well.
Do all trigger fingers need a procedure?
No. Mild symptoms can sometimes improve with activity modification, temporary splinting, anti-inflammatory medication when medically appropriate, and time. The decision to escalate treatment depends more on persistent pain and mechanical catching than on the name of the diagnosis alone.
A finger that repeatedly locks, interferes with work or daily activities, or stays symptomatic despite conservative treatment deserves a more detailed evaluation.
Option 1: Cortisone injection
A corticosteroid injection places anti-inflammatory medication around the flexor tendon sheath near the A1 pulley. The goal is to reduce swelling enough for the tendon to glide more freely.
Cortisone is attractive because it is quick, nonsurgical, and often effective. A meta-analysis of randomized trials found corticosteroid injection more effective than control injections, with successful treatment in roughly two-thirds of participants overall. Results vary among studies, steroid preparations, patient populations, and definitions of success. A 2022 meta-analysis of randomized trials supports corticosteroid injection as an evidence-based nonsurgical treatment.
A newer systematic review of randomized trials also found meaningful remission with corticosteroid treatment, while emphasizing that outcomes differ by medication and that the evidence does not establish one universally best injection technique for every patient. The 2026 systematic review is useful context when discussing injection choices.
What are the advantages of an injection?
For an appropriate patient, an injection can offer several practical advantages:
- no incision;
- little interruption of daily life;
- relatively fast treatment in the office;
- the possibility of avoiding a release procedure altogether; and
- the ability to reassess if symptoms do not adequately improve.
What are the limitations?
The main limitation is recurrence or incomplete relief. Cortisone can calm the inflammation without permanently enlarging the narrowed pulley. Some fingers improve for a long time. Others improve temporarily and begin catching again.
A randomized clinical trial comparing injection, percutaneous release, and open release found better durability with release procedures than with corticosteroid treatment. That randomized trial illustrates why recurrent triggering after injection changes the treatment conversation.
Potential injection risks include temporary soreness, steroid flare, skin color or fat changes at the injection site, temporary blood-sugar elevation in people with diabetes, infection, and very uncommon tendon injury. Individual risk depends on the medication, technique, medical history, and number of prior injections.
Option 2: Trigger finger release
A trigger finger release treats the mechanical bottleneck directly by opening the A1 pulley so the tendon has more room to glide.
Traditional open release remains an established treatment. A small incision is made in the palm, the pulley is identified and released, and the tendon is checked for free movement.
A percutaneous release uses a much smaller skin entry point. With ultrasound guidance, the clinician can visualize the tendon, pulley, nearby nerves and vessels, and the release instrument in real time rather than relying only on surface landmarks.
That distinction matters. Ultrasound guidance is not simply about making an incision smaller. Its purpose is to help the operator understand the anatomy continuously during a minimally invasive release.
How strong is the evidence for ultrasound-guided release?
The evidence is encouraging, but patients should understand its maturity.
A 2024 systematic review and meta-analysis comparing ultrasound-guided release with other trigger-finger release methods included randomized and observational studies. It found similar surgical success with potential advantages in early function and return to activity. Read the systematic review and meta-analysis.
Another 2024 systematic review comparing ultrasound-guided release with open surgery found favorable early functional outcomes for ultrasound-guided treatment. That review is available through PubMed.
These findings are promising, but they do not mean ultrasound-guided release is automatically superior for every patient or every trigger digit. Study techniques and devices vary, operator experience matters, and open release has a much longer clinical track record.
Cortisone injection vs ultrasound-guided release: how do you choose?
A useful way to think about the decision is reversible treatment versus definitive mechanical treatment.
Cortisone often makes sense when:
- this is a first episode of uncomplicated trigger finger;
- the finger still moves and is not persistently locked;
- symptoms have not already failed an appropriate injection strategy;
- avoiding a procedure is a high priority; or
- the diagnosis is clear and there is a reasonable chance inflammation reduction will restore smooth tendon motion.
Release becomes more attractive when:
- the finger is repeatedly or severely locking;
- symptoms returned after one or more injections;
- the problem has become functionally limiting;
- there is a fixed mechanical block that is unlikely to respond adequately to medication alone; or
- the patient prefers a treatment aimed directly at the narrowed pulley after discussing risks and alternatives.
There is no rule that every patient must receive multiple injections before considering release. Likewise, having trigger finger does not automatically mean you need surgery.
Does ultrasound make the cortisone injection better?
Ultrasound can help confirm anatomy and guide needle placement, but evidence has not shown that ultrasound guidance universally transforms the success rate of every trigger-finger steroid injection. The value may be greater when anatomy is uncertain, another diagnosis is being considered, or precise visualization is particularly useful.
That is different from ultrasound-guided release, where real-time imaging is used to visualize the structures during the actual mechanical release.
What if I have diabetes?
Trigger finger is more common in people with diabetes, and treatment decisions deserve extra discussion. Steroid injections can temporarily raise blood glucose, and injection success may differ in some diabetic populations. Patients who monitor glucose should ask how closely they should watch their readings after an injection.
Diabetes does not automatically rule out either injection or release. It simply makes individualized risk-benefit discussion more important.
What is recovery like after release?
Recovery depends on the technique, the severity and duration of the trigger finger, other hand conditions, and the demands placed on the hand.
After a successful release, finger motion is generally encouraged rather than keeping the hand completely still. Tenderness, swelling, and stiffness can occur while tissues recover. Heavy gripping or high-load work may need to be modified temporarily.
A minimally invasive entry point does not mean there is zero recovery or zero risk. Patients still need instructions about wound care, activity, swelling, and warning signs.
What are the risks of trigger finger release?
Potential complications include pain, swelling, stiffness, infection, incomplete release, persistent or recurrent triggering, tendon injury, nerve or blood-vessel injury, scar sensitivity, and complex regional pain syndrome. Serious complications are uncommon, but no procedure is risk-free.
Ultrasound guidance can improve visualization of important anatomy, but it does not eliminate the need for careful technique and appropriate patient selection.
Could something else be causing my finger symptoms?
Yes. Not every painful or stiff finger is trigger finger. Arthritis, tendon injury, cysts, Dupuytren disease, nerve problems, infection, and other conditions can sometimes mimic parts of the presentation.
Evaluation becomes particularly important when there has been an injury, the diagnosis is uncertain, several fingers are involved, there is substantial swelling, or symptoms do not behave like a typical trigger finger.
When should I seek prompt evaluation?
Seek medical attention promptly for rapidly increasing redness or swelling, drainage, fever with a painful hand, a new inability to move the finger after an injury, loss of sensation, or a finger with concerning color or circulation changes.
A chronically locked finger also deserves evaluation rather than repeatedly forcing it straight.
Dr. Morton’s clinical perspective
The most useful treatment decision starts by defining the actual problem. Is this an early inflammatory trigger finger that has a good chance of responding to an injection? Is the finger mechanically locking despite prior treatment? Is the diagnosis really trigger finger, or is another hand problem contributing?
For many first-time cases, a cortisone injection remains a reasonable nonsurgical option. For persistent, recurrent, or functionally significant triggering, release can address the mechanical narrowing more directly. Ultrasound-guided release is an increasingly useful minimally invasive option in appropriately selected patients, while open release remains an established standard.
The goal is not to choose the newest or most aggressive treatment. It is to choose the treatment that best matches the patient’s anatomy, symptoms, prior treatment, risks, and goals.
Schedule an evaluation for persistent trigger finger
If your finger keeps catching, locking, or limiting daily activities, Pacific Bone & Joint can evaluate the cause and discuss whether observation, injection, or trigger finger release using ultrasound guidance fits your situation. Request an orthopedic appointment to review your options.
Sources and further reading
- Pathak SK, et al. Corticosteroid Injection for the Treatment of Trigger Finger: A Meta-Analysis of Randomised Control Trials. J Hand Surg Asian Pac Vol. 2022. PubMed
- Kuper G, et al. Comparative effectiveness of corticosteroid injections for trigger finger: A systematic review of randomized controlled trials. J Plast Reconstr Aesthet Surg. 2026. PubMed
- Garcia HRP, et al. Ultrasound-guided vs. non-guided trigger finger release: a systematic review and meta-analysis. Int Orthop. 2024. PubMed
- Amro S, et al. Efficacy of Ultrasound-Guided Tendon Release for Trigger Finger Compared With Open Surgery: A Systematic Review and Meta-Analysis. J Ultrasound Med. 2024. PubMed
- Sato ES, et al. Treatment of trigger finger: randomized clinical trial comparing corticosteroid injection, percutaneous release and open surgery. Rheumatology. 2012. PubMed
